1.Cutaneous Metastasis Presenting as an Indurated Plaque Preceding the Diagnosis of Lung Adenocarcinoma.
Eo Gin LEE ; Kyu Young SEO ; Sang Eun LEE ; Hee Jung LEE ; Moon Soo YOON
Korean Journal of Dermatology 2014;52(1):59-60
No abstract available.
Adenocarcinoma*
;
Diagnosis*
;
Lung Neoplasms
;
Lung*
;
Neoplasm Metastasis*
2.Ophthalmoplegia in Herpes Zoster Ophthalmicus.
Kyu Young SEO ; Eo Gin LEE ; Moon Soo YOON ; Hee Jung LEE
Korean Journal of Dermatology 2012;50(10):927-928
No abstract available.
Herpes Zoster
;
Herpes Zoster Ophthalmicus
;
Mydriasis
;
Oculomotor Nerve Diseases
;
Ophthalmoplegia
3.A Case Report of Malignant Hyperthermia during Anesthesia.
Jong Hyon HWANG ; Young Gin LEE ; Sung WOO ; Kang Hee CHO
Korean Journal of Anesthesiology 1993;26(3):576-580
Malignant hyperthermia is a potentially fatal hypermetabolic syndrome characterised by hyperpyrexia and skeletal muscle rigidity. It can be induced by all of the currently used inhalation anesthetics or by injection of succinylcholine. A case of malignant hyperthermia was experienced which developed 80 minute after induction of general anesthesia with thiopental sodium, suecinylcholine, halothane, N2O and O2. One and half hours after induction, arrhythmia developed and was followed by unstable blood pressure, hyperpyrexia and muscle rigidity. Anesthesia was terminated and vigorous emergency treatment and dantrolene were administered. The patient recovered normal body temperature and consciousness, but expired about 4 days after induction because of late complication including disseminated intravascular coaggulation. The etiologic factor, clinieal feature, treatment and prevention of Malignant hyperthermia are discussed.
Anesthesia*
;
Anesthesia, General
;
Anesthetics, Inhalation
;
Arrhythmias, Cardiac
;
Blood Pressure
;
Body Temperature
;
Consciousness
;
Dantrolene
;
Emergency Treatment
;
Halothane
;
Humans
;
Malignant Hyperthermia*
;
Muscle Rigidity
;
Muscle, Skeletal
;
Succinylcholine
;
Thiopental
7.A Case of Brunner's Gland Adenoma Treated by Endoscopic Polypectomy.
Bai Young KIM ; Ji Young HAN ; Moo Youb CHOO ; Gyo Sung HWANG ; Nam Hoon KIM ; Gin Bum KIM ; Hwan Gon YOUN ; Young Cheol KWON ; Joo Tak LEE
Korean Journal of Gastrointestinal Endoscopy 1995;15(4):747-753
The Brunner's gland adenoma is characterized by a nodular proliferation of histologically normal Brunner's gland, accompanied by ducts and scattered stromal elements. First descrived by Salvioli in 1876, the tumor is relatively rare, with 119 cases reported by 1977, The most common benign tumor of the small bowel is the adenoma, 25% of which occur in the duodenum. They make up 30% to 50% of all hyperplastic polyps of the duodenum. Most frequently these tumors are discovered in patients in the fourth to sixed decades of life, though the age in reported caes ranges from l 1 days to 80 years. The benign tumors of the duodenum 30% to 50% contain elements of Brunner's gland and 10.6% of them are adenomas of Brunner's gland. We report a case of Brunner's gland adenoma treated by endoscopic polypectomy in 63 year-old woman, and reviewed the literatues of adenoma of the Brunne'r gland.
Adenoma*
;
Duodenum
;
Female
;
Gastrointestinal Hemorrhage
;
Humans
;
Middle Aged
;
Polyps
8.Clinical Relevance of Clinicopathologic Parameters and Tumor Markers in Ductal Carcinoma in Site of the Breast.
Hyun Chul KIM ; Eun Young SONG ; Soo Gin JUNG ; Hye Kyung YOON ; Jin Yong LEE
Journal of the Korean Surgical Society 2003;65(4):284-294
PURPOSE: Ductal carcinoma in situ (DCIS) of the breasts is a heterogeneous group of lesions with diverse malignant potentials and controversial treatment options. This study was planned to investigate the patterns of clinicopathologic parameters and tumor markers related to biological aggressiveness and to make treatment decisions available based on a variety of these parameters. METHODS: We reviewed forty cases of DCIS treated at Pusan Paik Hospital from March 1992 to July 2002. Clinicopathologic features such as age, chief complaint, mammographic finding, tumor size, histologic subtype, and operation type were analysed, and the expression of ER, PR, p53, C- erbB-2, cathepsin D, bcl-2, MIB-1 and CD34 were evaluated using immunohistochemical methods. RESULTS: The size of the tumor was less than 1.5 cm in 16 (44.4%) cases, 1.5 cm to 4 cm in 17 (47.2%) cases, and more than 4 cm in 3 (8.3%) cases. There were 11 (27.5%) cases of the comedo subtype and 29 (72.5%) cases of the noncomedo subtype. Nuclear grade was divided into low (8 cases, 20.0%), intermediate (20 cases, 50.0%), and high (12 cases, 30.0%). According to Van Nuys' classification, there were 25 (62.5%) cases, 4 (10.0%) cases, and 11 (27.5%) cases of group I, II, and III, respectively. The groups presenting as mass on mammogram had no significant relationship with those presenting as microcalcification in terms of tumor size, histologic subtype, nuclear grade, and Van Nuys classification. The expression rates of PR, p53, C-erbB-2, cathepsin D, and bcl-2 were 32.4%, 67.6%, 35.1%, 29.7%, 67.6%, and 45.9%, respectively. High MIB-1 labelling index (LI) and high microvessel density were observed in 8.1% and 32.4%, respectively. The group presenting as mass on mammogram showed higher ER (P=0.0276) and PR (P=0.102) expression, compared with the microcalcification group. Positive ER and PR were associated with low nuclear grade (P=0.0233, 0.1727), while positive p53 and C-erbB-2 and high MIB-1 LI correlated with Van Nuys' group III (P=0.0637, 0.0532). Positive ER correlated with positive PR (P=0.0581) and negative C-erbB-2 (P=0.0642). In addition, there were positive associations between PR and bcl-2 expression (P=0.0939), between p53, C-erbB-2 (P<0.0001) and high MIB-1 labelling index (P= 0.0785), and between cathepsin D and high microvessel density (P= 0.0151). CONCLUSION: Clinico-pathologic evaluation of tumor size, histologic subtype, nuclear grade, and Van Nuys classification can help predict more aggressive immunophenotypes of DCIS. Positive p53 and C-erbB-2 and high MIB-1 is associated not only with more aggressive clinical behavior and more advanced histologic features of DCIS, but also with negative ER, PR, and bcl-2. Our results support the clinical relevance of combining both clinico-pathologic factors and biologic tumor markers for determining the treatment modality in DCIS patients.
Biomarkers, Tumor*
;
Breast*
;
Busan
;
Carcinoma, Ductal*
;
Carcinoma, Intraductal, Noninfiltrating
;
Cathepsin D
;
Classification
;
Humans
;
Microvessels
9.Cerebellopontine Angle Lipoma Representing Trigeminal Neuralgia: Case Report.
Choong Seon YOO ; Han Kyu KIM ; Yong Soon HWANG ; Jae Gin MOON ; Hwa Dong LEE ; Young Duk JOH
Journal of Korean Neurosurgical Society 1994;23(11):1344-1348
A case of rare symptomatic cerebellopontine angle lipoma treated by surgical decompression is described. In this 28-year-old male with intermittent facial pain 17 years, a mass was noted in the right cerebellopontine angle on C-T and MRI. Partial removal of the mass was made for decompression of the lesion from the trigeminal nerve root entry zone. The surgical biopsy results was lipoma. This represents, to our knowledge, the first lipoma in the cerebellopontine angle reportes in the Korean literature.
Adult
;
Biopsy
;
Cerebellopontine Angle*
;
Decompression
;
Decompression, Surgical
;
Facial Pain
;
Humans
;
Lipoma*
;
Magnetic Resonance Imaging
;
Male
;
Neuroma, Acoustic
;
Trigeminal Nerve
;
Trigeminal Neuralgia*
10.Oral malodor prevention effect of toothpaste containing 0.5% zinc citrate and 1,450 ppm fluoride
Sung-Gin KIM ; Suk-Bin JANG ; Jae-Young LEE ; Ja-Won CHO
Journal of Korean Academy of Oral Health 2022;46(4):212-216
Objectives:
This study aims to verify the effect of the use of a toothpaste containing 0.5% zinc citrate and 1,450 ppm fluoride on oral malodor.
Methods:
In this study, the experimental group using the experimental toothpaste and the control group using the standard toothpaste control toothpaste were allowed to use each toothpaste for 4 weeks and then a clinical test to measure the change in bad breath was conducted. A study was conducted to evaluate the reduction effect. Efficacy was evaluated by conducting BB checker test and Oralchroma test three times in total before the testing 2 weeks and 4 weeks after the test.
Results:
As a result of measuring the degree of bad breath using the BB checker, before the start of the test, the experimental group was 46.3 and the control group was 47.2. After 2 weeks of the test, the experimental group was 38.5 and the control group was 44.2 and after 4 weeks the experimental group was 29.6 and the control group was 39.2. There was a significant difference between the experimental group and the control group after 4 weeks of the test (P<0.05). The volatile sulfur compounds measured by Oralchroma were 0.825 ng/10 ml for the experimental group and 0.819 ng/10 ml for the control group after 2 weeks of the test, and they were 0.705 ng/10 ml for the experimental group and 0.860 ng/10ml for the control group after 4 weeks of the test. It was confirmed that a significant index change appeared after 4 weeks of the test compared to before the test (P<0.05).
Conclusions
It was confirmed that an improved effect of removing bad breath can be expected when a toothpaste containing 0.5% zinc citrate and 1,450 ppm fluoride is used.